Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
3.050
-0.010 (-0.33%)
Mar 4, 2026, 4:00 PM EST - Market closed
ACTU's stock price has decreased by -53.15% in the past year and price targets may not have had time to catch up.
Actuate Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+555.74%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +555.74% | Nov 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +555.74% | Sep 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +555.74% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +555.74% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +555.74% | Mar 17, 2025 |